This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nikitin, A. Y. Articles by Lee, W.-H. Search for Related Content PubMed PubMed Citation Articles by Nikitin, A. Y. Articles by Lee, W.-H.

Cell Lineage-specific Effects Associated with Multiple Deficiencies of Tumor Susceptibility Genes in Msh2^-/-Rb^+/- Mice¹

Department of Molecular Medicine and Institute of Biotechnology, The University of Texas Health Science Center, San Antonio, Texas 78245-3207

Cooperative effects of genetic alterations are frequently observed during carcinogenesis.Mice carrying germ-line mutations in both Rb and p53 or Msh2 and p53 die earlier of tumors than mice with only one of these genes inactivated. Mice with a single wild-type Rb allele develop a syndrome of multiple neuroendocrine neoplasia, and inactivation of both alleles of Msh2 gene predisposes mice to gastrointestinal cancer, lymphomas and tumors of the skin that exhibit a mismatch repair defect. Here we showed that Msh2^-/-Rb^+/- mice developed lymphomas later than Msh2-deficient littermates, and the lymphomas observed in Msh2^-/-Rb^+/- mice have increased rates of apoptosis and rarely spread to other organs and tissues. In contrast to lymphomagenesis, courses of neuroendocrine, intestinal, and skin carcinogenesis were not significantly influenced by the Msh2^-/-Rb^+/- genetic combination. In these mice, neuroendocrine tumors displayed a loss of the remaining wild-type Rb allele but did not show microsatellite instability. On the other hand, the intestinal and skin tumors exhibited microsatellite instability but kept the remaining wild-type allele of Rb. Taken together, these data not only revealed a novel biological interaction between Rb and Msh2 but also cell lineage specificity effects associated with multiple deficiencies in these tumor susceptibility genes.

This article has been cited by other articles:

				T. T. Schug, D. C. Berry, I. A. Toshkov, L. Cheng, A. Y. Nikitin, and N. Noy Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPAR{beta}/{delta} to RAR PNAS, May 27, 2008; 105(21): 7546 - 7551. [Abstract] [Full Text] [PDF]

				J. M. Ward and D. E. Devor-Henneman Mouse Models of Human Familial Cancer Syndromes Toxicol Pathol, January 1, 2004; 32(1_suppl): 90 - 98. [Abstract] [PDF]

				D. Manor, E. N. Shmidt, A. Budhu, A. Flesken-Nikitin, M. Zgola, R. Page, A. Yu. Nikitin, and N. Noy Mammary Carcinoma Suppression by Cellular Retinoic Acid Binding Protein-II Cancer Res., August 1, 2003; 63(15): 4426 - 4433. [Abstract] [Full Text] [PDF]

				A. Flesken-Nikitin, K.-C. Choi, J. P. Eng, E. N. Shmidt, and A. Yu. Nikitin Induction of Carcinogenesis by Concurrent Inactivation of p53 and Rb1 in the Mouse Ovarian Surface Epithelium Cancer Res., July 1, 2003; 63(13): 3459 - 3463. [Abstract] [Full Text] [PDF]